YAP promotes the expression of various target genes, including connective tissue growth factor (CTGF) and cysteine-rich angiogenic inducer 61 (CYR61), which are associated with mesenchymal differentiation7 and poor prognosis in CRC patients8. The gene discussed is CCN1; the disease is colorectal carcinoma.